These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36516614)

  • 1. Mitochondria as a target of third row transition metal-based anticancer complexes.
    Olelewe C; Awuah SG
    Curr Opin Chem Biol; 2023 Feb; 72():102235. PubMed ID: 36516614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
    Silva MJSA; Gois PMP; Gasser G
    Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
    Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ
    ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances and Therapeutic Journey of Schiff Base Complexes with Selected Metals (Pt, Pd, Ag, Au) as Potent Anticancer Agents: A Review.
    Khan S; Alhumaydhi FA; Ibrahim MM; Alqahtani A; Alshamrani M; Alruwaili AS; Hassanian AA; Khan S
    Anticancer Agents Med Chem; 2022; 22(18):3086-3096. PubMed ID: 35546764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
    Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer property and DNA binding interaction of first row transition metal complexes: A decade update.
    Dasmahapatra U; Maiti B; Alam MM; Chanda K
    Eur J Med Chem; 2024 Sep; 275():116603. PubMed ID: 38936150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
    Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
    Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation anticancer metallodrugs.
    Komeda S; Casini A
    Curr Top Med Chem; 2012; 12(3):219-35. PubMed ID: 22236158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7.
    Kostova I
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.
    Giorgi E; Binacchi F; Marotta C; Cirri D; Gabbiani C; Pratesi A
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation metal anticancer complexes: multitargeting via redox modulation.
    Romero-Canelón I; Sadler PJ
    Inorg Chem; 2013 Nov; 52(21):12276-91. PubMed ID: 23879584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoroorganic Metal Complexes in Therapeutics.
    Demkowicz S; Kozak W; Daśko M; Rachon J
    Mini Rev Med Chem; 2016; 16(17):1359-1373. PubMed ID: 27145849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Good Fashion is Evolution, Not Revolution" - Methods to Enhance Existing Anticancer Medicines, Primarily with the Use of Transition Metal.
    Guzowska M; Kalinowska M; Lewandowski W
    Anticancer Agents Med Chem; 2018; 18(4):476-487. PubMed ID: 29189181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
    Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
    Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine proteases as targets for metal-based drugs.
    Fricker SP
    Metallomics; 2010 Jun; 2(6):366-77. PubMed ID: 21072382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress and future potential for metal complexes as anticancer drugs targeting G-quadruplex DNA.
    Zhang J; Zhang F; Li H; Liu C; Xia J; Ma L; Chu W; Zhang Z; Chen C; Li S; Wang S
    Curr Med Chem; 2012; 19(18):2957-75. PubMed ID: 22519400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond platinums: gold complexes as anticancer agents.
    Nardon C; Boscutti G; Fregona D
    Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Targeted Anticancer Agents.
    Zheng W; Zhao Y; Luo Q; Zhang Y; Wu K; Wang F
    Curr Top Med Chem; 2017 Nov; 17(28):3084-3098. PubMed ID: 28685693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.